COVID-19 Updates
Latest News
New COVID-19 Vaccines That Target KP.2 Variant Available
Two mRNA vaccines target the KP.2 variant, while a third vaccine targets the JN.1 variant, a predecessor to KP.2.
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
Feature
Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers
But dissenting commissioners dispute the FTC’s authority to broadly ban noncompetes.
Conference Coverage
Hormones and Viruses Influence Each Other: Consider These Connections in Your Patients
Infections with coronaviruses or other infectious agents like influenza can significantly worsen metabolic status, diabetes, and other endocrine...
Feature
Five Bold Predictions for Long COVID in 2024
If even one of these comes true, long COVID sufferers could enjoy some much-needed relief.
Latest News
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
The cohort consisted of 259,369 patients with COVID-19 and 259,369 uninfected controls.
From the Journals
Study: Unexpected vaginal bleeding rises after COVID vaccination
Researchers suggested it could have been connected to the SARS-CoV-2 spike protein in the vaccines.
From the Journals
People with long COVID have specific blood biomarkers, study says
The findings may be a step toward creating blood tests to positively identify people with long COVID so specialized treatments can be employed.
From the Journals
COVID booster may transiently raise glucose levels in T1D
“Clinicians, pharmacists, and other health care providers may need to counsel people with T1D to be more vigilant with glucose testing and insulin...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...
Latest News
New Moderna vaccine to work against recent COVID variant
The FDA is expected to approve the new Moderna shot by early October.